Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals

Naroa Goikoetxea‐Usandizaga, Marina Serrano‐Maciá, Teresa C. Delgado, Jorge Simón, David Fernández Ramos, Diego Barriales, Maria E. Cornide, Mónica Jiménez, Marina Pérez‐Redondo, Sofia Lachiondo‐Ortega, Rubén Rodríguez‐Agudo, Maider Bizkarguenaga, Juan Diego Zalamea, Samuel T. Pasco, Daniel Caballero‐Díaz, Benedetta Alfano, Miren Bravo, Irene González‐Recio, Maria Mercado‐Gómez, Clàudia Gil‐Pitarch, Jon Mabe, Jordi Gracia‐Sancho, Leticia Abecia, Óscar Lorenzo, Paloma Martín‐Sanz, Nicola G. A.

Oncogenic Activity of Solute Carrier Family 45 Member 2 and Alpha‐Methylacyl‐Coenzyme A Racemase Gene Fusion Is Mediated by Mitogen‐Activated Protein Kinase

Ze‐Hua Zuo, Yan‐Ping Yu, Bao‐Guo Ren, Silvia Liu, Joel Nelson, Zhou Wang, Junyan Tao, Tirthadipa Pradhan‐Sundd, Rohit Bhargava, George Michalopoulos, Qi Chen, Jun Zhang, Deqin Ma, Arjun Pennathur, James Luketich, Paul Satdarshan Monga, Michael Nalesnik, Jian‐Hua Luo – 9 September 2021 – Chromosome rearrangement is one of the hallmarks of human malignancies. Gene fusion is one of the consequences of chromosome rearrangements.

Telemedicine in Hepatology: Current Applications and Future Directions

Brian M. Fung, Megan Perumpail, Yuval A. Patel, James H. Tabibian – 9 September 2021 – Telemedicine refers to the use of information and communication technologies for providing health care at a distance. Through the use of telecommunication technologies such as cell phones, computers, and other electronic devices, health care providers are able to conduct patient visits, mentor/train other providers, and monitor patients’ chronic diseases remotely, potentially hundreds or thousands of miles away. Over the past 2 decades, the use of telemedicine has grown in the field of hepatology.

What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond?

Naim Alkhouri, Monica Tincopa, Rohit Loomba, Stephen A. Harrison – 8 September 2021 – Nonalcoholic steatohepatitis (NASH) can progress to cirrhosis and its complications, including hepatocellular carcinoma. Given that the majority of patients with NASH are asymptomatic, developing screening strategies to identify those individuals at risk for progressive NASH remains a highly unmet need.

Subscribe to